CERO THERAPEUTICS HOLDINGS, INC. Current Liabilities
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Current Liabilities of $32.41 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $32.41M.
- 2026-03-31: Liabilities, Current $11.33M.
- 2025-12-31: Liabilities, Current $9.09M.
- 2025-09-30: Liabilities, Current $8.45M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $32.41M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.33M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $9.09M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.45M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $7.62M 10-Q · filed 2025-08-22 | |
| 2025-03-31 | $7.86M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.40M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $9.42M 10-Q/A · filed 2024-11-20 | |
| 2024-06-30 | $8.78M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $11.65M 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $3.51M 10-K · filed 2025-04-15 | $5.17M 10-K · filed 2024-04-02 |
| 2023-09-30 | $4.80M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.41M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.29M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $30.75M 10-K · filed 2024-04-02 | |
| 2022-09-30 | $875.97K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $234.21K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $174.66K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $98.07K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $277.00K 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |